Search results
Results from the WOW.Com Content Network
Coronavirus diseases are caused by viruses in the coronavirus subfamily, a group of related RNA viruses that cause diseases in mammals and birds. In humans and birds, the group of viruses cause respiratory tract infections that can range from mild to lethal.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Coronavirus disease 2019 (COVID-19) Yes: Coxsackie B virus: Coxsackie B virus infection Enterovirus infection is diagnosed mainly via serological tests such as ELISA and from cell culture. There is no well-accepted treatment for the Coxsackie B group of viruses. Under research [10] PRNP
Sialodacryoadenitis virus (SDAV), which is a strain of the species Murine coronavirus, [143] is highly infectious coronavirus of laboratory rats, which can be transmitted between individuals by direct contact and indirectly by aerosol. Rabbit enteric coronavirus causes acute gastrointestinal disease and diarrhea in young European rabbits. [127]
It had a variant called B.1.1.7 that caused more severe disease. Alpha circulated from late 2020 to late 2021 before it was outcompeted by Delta and then Omicron. Our current vaccines are ...
Widespread non-communicable diseases such as cardiovascular disease and cancer are not included. An epidemic is the rapid spread of disease to a large number of people in a given population within a short period of time; in meningococcal infections , an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered ...
A carcinogen (/ k ɑːr ˈ s ɪ n ə dʒ ən /) is any agent that promotes the development of cancer. [1] Carcinogens can include synthetic chemicals , naturally occurring substances, physical agents such as ionizing and non-ionizing radiation , and biologic agents such as viruses and bacteria . [ 2 ]
Scientists are only starting to grasp the vast array of health problems caused by the novel coronavirus. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways ...
The authors came to the conclusion that no further trials of hydroxychloroquine or chloroquine for treatment of COVID-19 should be carried out. [58] On 26 April 2021, in its amended clinical management protocol for COVID-19, the Indian Ministry of Health lists hydroxychloroquine for use in patients during the early course of the disease. [23]